470 related articles for article (PubMed ID: 31932090)
1. A Collaborative Retrospective Study on the Efficacy and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema: The European DME Registry Study.
Rosenblatt A; Udaondo P; Cunha-Vaz J; Sivaprasad S; Bandello F; Lanzetta P; Kodjikian L; Goldstein M; Habot-Wilner Z; Loewenstein A;
Ophthalmology; 2020 Mar; 127(3):377-393. PubMed ID: 31932090
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema.
Castro-Navarro V; Cervera-Taulet E; Navarro-Palop C; Monferrer-Adsuara C; Hernández-Bel L; Montero-Hernández J
BMC Ophthalmol; 2019 Jan; 19(1):15. PubMed ID: 30634940
[TBL] [Abstract][Full Text] [Related]
3. [Early efficacy of dexamethasone implant (OZURDEX
Sarda V; Fajnkuchen F; Nghiem-Buffet S; Grenet T; Chaine G; Giocanti-Auregan A
J Fr Ophtalmol; 2017 May; 40(5):408-413. PubMed ID: 28336283
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab Injection for Treatment of Non-Proliferative Diabetic Macular Edema: A Prospective, Randomized and Blinded Trial.
Mishra SK; Sinha S; Chauhan R; Kumar A
Curr Drug Deliv; 2021; 18(6):825-832. PubMed ID: 33267762
[TBL] [Abstract][Full Text] [Related]
5. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
Callanan DG; Loewenstein A; Patel SS; Massin P; Corcóstegui B; Li XY; Jiao J; Hashad Y; Whitcup SM
Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215
[TBL] [Abstract][Full Text] [Related]
6. [Dexamethasone intravitreal implant (Ozurdex) in patients with diabetic macular edema: Real life safety and efficacy].
Majstruk L; Qu-Knafo L; Sarda V; Fajnkuchen F; Nghiem-Buffet S; Grenet T; Chaine G; Giocanti-Auregan A
J Fr Ophtalmol; 2020 Mar; 43(3):197-204. PubMed ID: 32000989
[TBL] [Abstract][Full Text] [Related]
7. A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: the BEVORDEX study.
Gillies MC; Lim LL; Campain A; Quin GJ; Salem W; Li J; Goodwin S; Aroney C; McAllister IL; Fraser-Bell S
Ophthalmology; 2014 Dec; 121(12):2473-81. PubMed ID: 25155371
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of dexamethasone intravitreal implant for the treatment of persistent diffuse diabetic macular edema.
Esen E; Sizmaz S; Demircan N
Int Ophthalmol; 2017 Feb; 37(1):1-6. PubMed ID: 26968412
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema: A Real-World Experience.
Mello Filho P; Andrade G; Maia A; Maia M; Biccas Neto L; Muralha Neto A; Moura Brasil O; Minelli E; Dalloul C; Iglicki M
Ophthalmologica; 2019; 241(1):9-16. PubMed ID: 30408801
[TBL] [Abstract][Full Text] [Related]
10. OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant.
Zur D; Iglicki M; Busch C; Invernizzi A; Mariussi M; Loewenstein A;
Ophthalmology; 2018 Feb; 125(2):267-275. PubMed ID: 28935399
[TBL] [Abstract][Full Text] [Related]
11. Real-World Assessment of Dexamethasone Intravitreal Implant in DME: Findings of the Prospective, Multicenter REINFORCE Study.
Singer MA; Dugel PU; Fine HF; Capone A; Maltman J
Ophthalmic Surg Lasers Imaging Retina; 2018 Jun; 49(6):425-435. PubMed ID: 29927470
[TBL] [Abstract][Full Text] [Related]
12. Predictive capacity of baseline hyperreflective dots on the intravitreal dexamethasone implant (Ozurdex®) outcomes in diabetic macular edema: a multicenter study.
Fonollosa A; Zarranz-Ventura J; Valverde A; Becerra E; Bernal-Morales C; Pastor-Idoate S; Zapata MA
Graefes Arch Clin Exp Ophthalmol; 2019 Nov; 257(11):2381-2390. PubMed ID: 31451909
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Diabetic Macular Edema with Multiple Dexamethasone Intravitreal Implants: Evidence from Real-Life Experience.
De Geronimo D; Giorno P; Scarinci F; Boninfante A; Varano M; Parravano M
Ophthalmologica; 2020; 243(6):413-419. PubMed ID: 31760387
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Intravitreal Dexamethasone Treatment in Eyes with Pretreated Chronic Diabetic Macular Edema.
Zandi S; Lereuil T; Freiberg F; Pfau M; Pfister IB; Gerhardt C; Michels S; Kodjikian L; Garweg JG
J Ocul Pharmacol Ther; 2017 Oct; 33(8):620-628. PubMed ID: 28836880
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone Implants in Diabetic Macular Edema Patients with High Visual Acuity.
Sacconi R; Battaglia Parodi M; Casati S; Lattanzio R; Marchini G; Bandello F
Ophthalmic Res; 2017; 58(3):125-130. PubMed ID: 28704825
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone Intravitreal Implant for Chronic Diabetic Macular Edema Resistant to Intravitreal Bevacizumab Treatment.
Totan Y; Güler E; Gürağaç FB
Curr Eye Res; 2016; 41(1):107-13. PubMed ID: 25610946
[TBL] [Abstract][Full Text] [Related]
17. REAL-LIFE STUDY IN DIABETIC MACULAR EDEMA TREATED WITH DEXAMETHASONE IMPLANT: The Reldex Study.
Malclès A; Dot C; Voirin N; Agard É; Vié AL; Bellocq D; Denis P; Kodjikian L
Retina; 2017 Apr; 37(4):753-760. PubMed ID: 27471826
[TBL] [Abstract][Full Text] [Related]
18. Dexamethasone implant in diabetic macular edema in real-life situations.
Chhablani J; Bansal P; Veritti D; Sambhana S; Sarao V; Pichi F; Carrai P; Massaro D; Lembo A; Mansour AM; Banker A; Gupta SR; Hamam R; Lanzetta P
Eye (Lond); 2016 Mar; 30(3):426-30. PubMed ID: 26611849
[TBL] [Abstract][Full Text] [Related]
19. Vitrectomy Combined with Intraoperative Dexamethasone Implant for the Management of Refractory Diabetic Macular Edema.
Kim KT; Jang JW; Kang SW; Chae JB; Cho K; Bae K
Korean J Ophthalmol; 2019 Jun; 33(3):249-258. PubMed ID: 31179656
[TBL] [Abstract][Full Text] [Related]
20. Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema: A DRCR Network Phase 2 Randomized Clinical Trial.
Maturi RK; Glassman AR; Liu D; Beck RW; Bhavsar AR; Bressler NM; Jampol LM; Melia M; Punjabi OS; Salehi-Had H; Sun JK;
JAMA Ophthalmol; 2018 Jan; 136(1):29-38. PubMed ID: 29127949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
